Scripps Research’s Post

Really interesting study that I was a part of at University of Maryland School of Medicine, which examines how septic cargo carried by EVs relates with neuroinflammation!! One of the most fascinating studies that I ever contributed to and I’m grateful to have been a part of this research. Check out the full article here: https://lnkd.in/erXXKTc8

Been meaning to post this, better late than never. We have a new paper in Clinical Science, based on the fabulous work Samar Salem did during her PhD with me. And we made the cover page!

Are you working in basic biology and have thoughts about new approaches to accurately model human biology in platforms other than animal models? Are there complementary approaches you would propose? Check out this prize competition sponsored by the Common Fund and get your ideas in! #NewApproachMethodologies #NAMs #ReplaceReduceRefine #Biomedicalresearch #PrizeCompetition

“When we think about the science we want to support, [we ask,] ‘Who does the science? What science is being done? Who does the science serve? ... Fundamentally, ‘Is the science that we’re doing inclusive of everyone?’” says Bil Clemons, PhD, science program officer for Diversity, Equity, and Inclusion in Science for CZI. Experts warn that new technologies that tailor health care to individuals may exacerbate health inequities. Several academic medical centers are seeking to address this with a range of strategies, from expanding personalized medicine research at HBCU medical schools to engaging community partners for research recruitment. Learn more in part two of a two-part series, where AAMCNews explores the promise and limitations of the field of personalized medicine: https://ow.ly/BA8250QO1E1.

Today we are proud to announce funding of Copenhagen Center for Biomedical Quantum Sensing. With a grant of DKK 150 million over 6 years from the Novo Nordisk Foundation, researchers from three universities aim to advance quantum sensing and imaging technologies for use in medical diagnostics and healthcare. Quantum sensing and imaging were among the first breakthrough results I worked on as a postdoc back in the day. We reported that quantum "ghost" imaging could equally well be done classical states, and that "quantum advantage" was an elusive target, requiring significant effort to reach. It therefore pleases me immensely to observe how this exciting technology has improved 2 decades later. In fact, of all the quantum technologies, this is the most mature. In the past year I have therefore been leading the Novo Nordisk Foundation's effort in developing a new research centre within quantum sensing. The Copenhagen Center for Biomedical Quantum Sensing will have 3 strong quantum optics labs joining forces 👉Eugene Polzik at the Niels Bohr Institute, University of Copenhagen 👉Ulrik L. Andersen at DTU Physics, DTU - Technical University of Denmark 👉Mark Raizen, The University of Texas at Austin. In collaboration with hospitals and biomedical experts, the vision is to develop novel atomic and quantum-enabled methods that can be applied to some of the most urgent health problems, such as early diagnosis of heart and brain anomalies, detecting metabolic changes in the body, preventing malnutrition, nerve degeneration and the response to antibiotics. The primary goals of the Center are ✔️ to develop and use novel quantum sensing principles and techniques for biomedical diagnostics that can operate near and beyond standard quantum limits of sensitivity ✔️ to provide ultrasensitive platforms for early detection of disease ✔️ to enable investigations into cellular systems at an unprecedented scale and precision. The international quantum sensing research collaboration will consolidate and significantly strengthen the quantum sensing activities in Denmark, educate tomorrow's talent, and enable translation into clinical applications. The Copenhagen Center for Biomedical Quantum Sensing will join the Novo Nordisk Foundation's recent substantial investments in quantum technologies, including a grant to the NNF Quantum Computing Programme (NQCP) and Quantum Foundry Copenhagen. The new Center is in the first phase funded by the Novo Nordisk Foundation, and phase 2 funding will be sought in partnership with the Pointsman Foundation, an independent non-profit foundation based in Austin, Texas. Stefania Xella, Karin Hultman, Rikke Vibeke Nielsen, Cathal J. Mahon, Lene B. Oddershede, Mikkel Bülow Skovborg, Henrik Barslund Fosse, Rikke Stefansen, Jakob Stein, Christian Mostrup, Sabina Askholm Larsen #QuantumSensing #quantumtechnologies #MedicalDiagnostics #HealthcareInnovation #QuantumEnabledMethods #HealthResearch #CollaborativeScience #dkforsk

💬 "If I had any advice for young scientists: utilize your strength. We all have weaknesses. Compensate for those weaknesses and once you define them and if you keep chipping away ..." — Dr. Lynne Maquat FRAXA has been funding Dr. Maquat's research on Fragile X since 2021. Her groundbreaking work on RNA biology has advanced our understanding of Fragile X syndrome. She was just honored with the 2024 Albany Medical Center Prize in Medicine and Biomedical Research; only 2 weeks ago, she also received the Dr. Paul Janssen Award for Biomedical Research. Let’s keep pushing the boundaries of science, just like Dr. Maquat! 👏 #FragileX #FXResearch #RNA #BiomedicalResearch #WomenInScience #MedicalInnovation #RareDiseases #NeurologicalDisorders #CysticFibrosis #URMC #Perseverance

P. ZAFIROPOULOS S.A. is delighted to announce that today begins the 12th Panhellenic Conference of the Hellenic Society of Clinical & Molecular Cytology, which will take place at the War Museum in Athens from September 27 to 29, 2024. The 12th Panhellenic Conference will provide an invaluable platform for leading experts, including Cytologists, molecular biologists, medical technologists, and physicians, to engage with the latest innovations in cytological techniques and more. This year’s conference will delve into exciting advancements in the clinical applications of biomarker development, molecular techniques, and innovative methods for sample processing—key areas that align with our mission to drive innovation in healthcare. The event promises to foster dynamic discussions, expert lectures, and educational sessions, covering topics crucial for professionals working at the intersection of clinical practice and medical research. With expert-led discussions, hands-on educational seminars, and valuable networking opportunities, this conference will undoubtedly be a highlight for the Cytology community. For more information, please follow the links below: https://lnkd.in/d4BX7b-g https://lnkd.in/djcduuhN #Cytology2024 #ClinicalCytology #PrecisionMedicine #MolecularCytology  #HealthcareAdvancements #AdvancingLifesciences #InnovatingHealthcare

Younger me was terrified of submitting a paper to any journal - thoughts of rejection and failure were dominant; it felt like being back at school handing in an exam, and the teacher corrected it with a red pen - no feedback, no learning curve. Publishing is different; it is a communication channel with your peers, the Editor, and you to lift up your work. Keen to hear insights from Editors from #Cell #NatureMethods #Science and #BiochemicalSociety? Join us at the end of the month for our ACDS workshop on "From Pitch to Publication - Insights from Editors"

ASIA 2024 PRECOURSES - REGISTER NOW! Researchers, Clinicians, and other SCI Professionals are invited to join us for the 2024 Annual Scientific Meeting, May 20-23 in San Juan, Puerto Rico. The conference will include three-and-a-half days of Precourses, Courses, General Sessions, Posters, and endless networking.  Precourse 1 DME and Accessibility: The Essence for Maintaining Autonomy and Independence of People with a Spinal Cord Injury A collaborative one-day workshop organized by three ASIA Committees (Americas, Rehabilitation Standards and Education) to enhance the knowledge of spinal cord injury care for any provider involved in the care of this patient population in the United States and abroad. Precourse 2 From Molecules to Movement – Scope, Utility, and Application of Biomarkers for SCI Clinical Trials and the Development of SCI Precision Medicine Spinal Cord Outcomes Partnership Endeavor (SCOPE) This pre-course is tailored for SCI clinicians, preclinical and clinical researchers as well as biomarker scientists

Check out this breakthrough publication from Brian Lin and Jay Rajagopal’s Lab!